nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—CYP3A4—Esomeprazole—Barrett's esophagus	0.194	0.629	CbGbCtD
Danazol—CYP3A4—Omeprazole—Barrett's esophagus	0.114	0.371	CbGbCtD
Danazol—CCL2—exocrine gland—Barrett's esophagus	0.0295	0.271	CbGeAlD
Danazol—Nodule—Esomeprazole—Barrett's esophagus	0.0225	0.0563	CcSEcCtD
Danazol—Nodule—Omeprazole—Barrett's esophagus	0.0225	0.0563	CcSEcCtD
Danazol—Epigastric pain—Esomeprazole—Barrett's esophagus	0.0137	0.0343	CcSEcCtD
Danazol—Epigastric pain—Omeprazole—Barrett's esophagus	0.0137	0.0343	CcSEcCtD
Danazol—CCL2—epithelium—Barrett's esophagus	0.0128	0.118	CbGeAlD
Danazol—CCL2—smooth muscle tissue—Barrett's esophagus	0.0123	0.113	CbGeAlD
Danazol—CCL2—AP-1 transcription factor network—CRTC1—Barrett's esophagus	0.0107	0.06	CbGpPWpGaD
Danazol—CCL2—digestive system—Barrett's esophagus	0.00975	0.0896	CbGeAlD
Danazol—Leukocytosis—Esomeprazole—Barrett's esophagus	0.00703	0.0176	CcSEcCtD
Danazol—Leukocytosis—Omeprazole—Barrett's esophagus	0.00703	0.0176	CcSEcCtD
Danazol—PGR—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00696	0.0391	CbGpPWpGaD
Danazol—PGR—epithelium—Barrett's esophagus	0.00674	0.0619	CbGeAlD
Danazol—PGR—smooth muscle tissue—Barrett's esophagus	0.00649	0.0596	CbGeAlD
Danazol—Fluid retention—Omeprazole—Barrett's esophagus	0.00628	0.0157	CcSEcCtD
Danazol—Fluid retention—Esomeprazole—Barrett's esophagus	0.00628	0.0157	CcSEcCtD
Danazol—Ethinyl Estradiol—NR1I2—Barrett's esophagus	0.00573	1	CrCbGaD
Danazol—Sleep disorder—Esomeprazole—Barrett's esophagus	0.00554	0.0139	CcSEcCtD
Danazol—Sleep disorder—Omeprazole—Barrett's esophagus	0.00554	0.0139	CcSEcCtD
Danazol—PGR—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.0055	0.0309	CbGpPWpGaD
Danazol—Hepatic function abnormal—Esomeprazole—Barrett's esophagus	0.00549	0.0137	CcSEcCtD
Danazol—Hepatic function abnormal—Omeprazole—Barrett's esophagus	0.00549	0.0137	CcSEcCtD
Danazol—Photosensitivity—Omeprazole—Barrett's esophagus	0.00546	0.0137	CcSEcCtD
Danazol—Photosensitivity—Esomeprazole—Barrett's esophagus	0.00546	0.0137	CcSEcCtD
Danazol—Gastroenteritis—Omeprazole—Barrett's esophagus	0.00541	0.0136	CcSEcCtD
Danazol—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.00541	0.0136	CcSEcCtD
Danazol—AR—epithelium—Barrett's esophagus	0.00537	0.0493	CbGeAlD
Danazol—AR—Nuclear Receptors—NR1I2—Barrett's esophagus	0.0053	0.0298	CbGpPWpGaD
Danazol—ESR1—epithelium—Barrett's esophagus	0.00527	0.0484	CbGeAlD
Danazol—AR—smooth muscle tissue—Barrett's esophagus	0.00517	0.0475	CbGeAlD
Danazol—ESR1—smooth muscle tissue—Barrett's esophagus	0.00508	0.0466	CbGeAlD
Danazol—Visual disturbance—Omeprazole—Barrett's esophagus	0.00506	0.0127	CcSEcCtD
Danazol—Visual disturbance—Esomeprazole—Barrett's esophagus	0.00506	0.0127	CcSEcCtD
Danazol—Migraine—Omeprazole—Barrett's esophagus	0.00472	0.0118	CcSEcCtD
Danazol—Migraine—Esomeprazole—Barrett's esophagus	0.00472	0.0118	CcSEcCtD
Danazol—Irritability—Esomeprazole—Barrett's esophagus	0.00458	0.0115	CcSEcCtD
Danazol—Irritability—Omeprazole—Barrett's esophagus	0.00458	0.0115	CcSEcCtD
Danazol—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00438	0.011	CcSEcCtD
Danazol—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00438	0.011	CcSEcCtD
Danazol—Cramp muscle—Esomeprazole—Barrett's esophagus	0.00432	0.0108	CcSEcCtD
Danazol—Cramp muscle—Omeprazole—Barrett's esophagus	0.00432	0.0108	CcSEcCtD
Danazol—CCL2—ATF4 activates genes—CXCL8—Barrett's esophagus	0.00424	0.0238	CbGpPWpGaD
Danazol—AR—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00419	0.0236	CbGpPWpGaD
Danazol—ESR1—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00409	0.023	CbGpPWpGaD
Danazol—AR—digestive system—Barrett's esophagus	0.00408	0.0375	CbGeAlD
Danazol—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00407	0.0102	CcSEcCtD
Danazol—Pancreatitis—Omeprazole—Barrett's esophagus	0.00407	0.0102	CcSEcCtD
Danazol—ESR1—digestive system—Barrett's esophagus	0.00401	0.0368	CbGeAlD
Danazol—CCL2—PERK regulates gene expression—CXCL8—Barrett's esophagus	0.00387	0.0217	CbGpPWpGaD
Danazol—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.00379	0.00948	CcSEcCtD
Danazol—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.00379	0.00948	CcSEcCtD
Danazol—Weight increased—Omeprazole—Barrett's esophagus	0.00377	0.00945	CcSEcCtD
Danazol—Weight increased—Esomeprazole—Barrett's esophagus	0.00377	0.00945	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.00367	0.00918	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.00367	0.00918	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—CRTC1—Barrett's esophagus	0.00362	0.0203	CbGpPWpGaD
Danazol—Jaundice—Esomeprazole—Barrett's esophagus	0.0036	0.00903	CcSEcCtD
Danazol—Jaundice—Omeprazole—Barrett's esophagus	0.0036	0.00903	CcSEcCtD
Danazol—Haematuria—Esomeprazole—Barrett's esophagus	0.00353	0.00883	CcSEcCtD
Danazol—Haematuria—Omeprazole—Barrett's esophagus	0.00353	0.00883	CcSEcCtD
Danazol—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—Barrett's esophagus	0.00341	0.0192	CbGpPWpGaD
Danazol—CCL2—IL23-mediated signaling events—RELA—Barrett's esophagus	0.00328	0.0185	CbGpPWpGaD
Danazol—CCL2—Ectoderm Differentiation—BMP4—Barrett's esophagus	0.00326	0.0183	CbGpPWpGaD
Danazol—ESR1—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00323	0.0181	CbGpPWpGaD
Danazol—Visual impairment—Omeprazole—Barrett's esophagus	0.0032	0.00801	CcSEcCtD
Danazol—Visual impairment—Esomeprazole—Barrett's esophagus	0.0032	0.00801	CcSEcCtD
Danazol—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00317	0.0178	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—SLC9A1—Barrett's esophagus	0.00314	0.0177	CbGpPWpGaD
Danazol—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.00314	0.00786	CcSEcCtD
Danazol—Erythema multiforme—Omeprazole—Barrett's esophagus	0.00314	0.00786	CcSEcCtD
Danazol—CYP19A1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00312	0.0176	CbGpPWpGaD
Danazol—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—Barrett's esophagus	0.00309	0.0174	CbGpPWpGaD
Danazol—Flushing—Omeprazole—Barrett's esophagus	0.00308	0.00771	CcSEcCtD
Danazol—Flushing—Esomeprazole—Barrett's esophagus	0.00308	0.00771	CcSEcCtD
Danazol—Chills—Esomeprazole—Barrett's esophagus	0.00298	0.00746	CcSEcCtD
Danazol—Chills—Omeprazole—Barrett's esophagus	0.00298	0.00746	CcSEcCtD
Danazol—CCL2—TWEAK Signaling Pathway—RELA—Barrett's esophagus	0.00297	0.0167	CbGpPWpGaD
Danazol—Alopecia—Esomeprazole—Barrett's esophagus	0.00293	0.00735	CcSEcCtD
Danazol—Alopecia—Omeprazole—Barrett's esophagus	0.00293	0.00735	CcSEcCtD
Danazol—GNRHR—G alpha (q) signalling events—GAST—Barrett's esophagus	0.0029	0.0163	CbGpPWpGaD
Danazol—Tension—Omeprazole—Barrett's esophagus	0.00284	0.0071	CcSEcCtD
Danazol—Tension—Esomeprazole—Barrett's esophagus	0.00284	0.0071	CcSEcCtD
Danazol—Nervousness—Omeprazole—Barrett's esophagus	0.00281	0.00703	CcSEcCtD
Danazol—Nervousness—Esomeprazole—Barrett's esophagus	0.00281	0.00703	CcSEcCtD
Danazol—Back pain—Esomeprazole—Barrett's esophagus	0.0028	0.007	CcSEcCtD
Danazol—Back pain—Omeprazole—Barrett's esophagus	0.0028	0.007	CcSEcCtD
Danazol—Muscle spasms—Esomeprazole—Barrett's esophagus	0.00278	0.00696	CcSEcCtD
Danazol—Muscle spasms—Omeprazole—Barrett's esophagus	0.00278	0.00696	CcSEcCtD
Danazol—Vision blurred—Esomeprazole—Barrett's esophagus	0.00272	0.00682	CcSEcCtD
Danazol—Vision blurred—Omeprazole—Barrett's esophagus	0.00272	0.00682	CcSEcCtD
Danazol—Tremor—Omeprazole—Barrett's esophagus	0.00271	0.00678	CcSEcCtD
Danazol—Tremor—Esomeprazole—Barrett's esophagus	0.00271	0.00678	CcSEcCtD
Danazol—Vertigo—Esomeprazole—Barrett's esophagus	0.0026	0.0065	CcSEcCtD
Danazol—Vertigo—Omeprazole—Barrett's esophagus	0.0026	0.0065	CcSEcCtD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.00259	0.0146	CbGpPWpGaD
Danazol—Leukopenia—Esomeprazole—Barrett's esophagus	0.00259	0.00648	CcSEcCtD
Danazol—Leukopenia—Omeprazole—Barrett's esophagus	0.00259	0.00648	CcSEcCtD
Danazol—CYP19A1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00257	0.0144	CbGpPWpGaD
Danazol—Palpitations—Esomeprazole—Barrett's esophagus	0.00255	0.00639	CcSEcCtD
Danazol—Palpitations—Omeprazole—Barrett's esophagus	0.00255	0.00639	CcSEcCtD
Danazol—CCL2—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.00254	0.0143	CbGpPWpGaD
Danazol—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00253	0.0142	CbGpPWpGaD
Danazol—Hypertension—Esomeprazole—Barrett's esophagus	0.00249	0.00625	CcSEcCtD
Danazol—Hypertension—Omeprazole—Barrett's esophagus	0.00249	0.00625	CcSEcCtD
Danazol—Arthralgia—Esomeprazole—Barrett's esophagus	0.00246	0.00616	CcSEcCtD
Danazol—Arthralgia—Omeprazole—Barrett's esophagus	0.00246	0.00616	CcSEcCtD
Danazol—Anxiety—Esomeprazole—Barrett's esophagus	0.00245	0.00614	CcSEcCtD
Danazol—Anxiety—Omeprazole—Barrett's esophagus	0.00245	0.00614	CcSEcCtD
Danazol—CCL2—IL-1 signaling pathway—RELA—Barrett's esophagus	0.00239	0.0134	CbGpPWpGaD
Danazol—Shock—Esomeprazole—Barrett's esophagus	0.00232	0.00581	CcSEcCtD
Danazol—Shock—Omeprazole—Barrett's esophagus	0.00232	0.00581	CcSEcCtD
Danazol—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.00231	0.00578	CcSEcCtD
Danazol—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.00231	0.00578	CcSEcCtD
Danazol—Tachycardia—Esomeprazole—Barrett's esophagus	0.0023	0.00576	CcSEcCtD
Danazol—Tachycardia—Omeprazole—Barrett's esophagus	0.0023	0.00576	CcSEcCtD
Danazol—PGR—Nuclear Receptors—PPARG—Barrett's esophagus	0.00229	0.0129	CbGpPWpGaD
Danazol—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.00228	0.00571	CcSEcCtD
Danazol—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.00228	0.00571	CcSEcCtD
Danazol—CYP3A4—digestive system—Barrett's esophagus	0.00224	0.0205	CbGeAlD
Danazol—CCL2—Chemokine receptors bind chemokines—CXCL8—Barrett's esophagus	0.00222	0.0125	CbGpPWpGaD
Danazol—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00215	0.00538	CcSEcCtD
Danazol—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00215	0.00538	CcSEcCtD
Danazol—CCL2—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.00215	0.0121	CbGpPWpGaD
Danazol—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00212	0.0053	CcSEcCtD
Danazol—Paraesthesia—Omeprazole—Barrett's esophagus	0.00212	0.0053	CcSEcCtD
Danazol—CCL2—Oncostatin M Signaling Pathway—RELA—Barrett's esophagus	0.00209	0.0118	CbGpPWpGaD
Danazol—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00208	0.0052	CcSEcCtD
Danazol—Dyspepsia—Omeprazole—Barrett's esophagus	0.00208	0.0052	CcSEcCtD
Danazol—CCL2—Folate Metabolism—RELA—Barrett's esophagus	0.00207	0.0116	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—CDKN2A—Barrett's esophagus	0.00205	0.0115	CbGpPWpGaD
Danazol—Fatigue—Omeprazole—Barrett's esophagus	0.00203	0.00509	CcSEcCtD
Danazol—Fatigue—Esomeprazole—Barrett's esophagus	0.00203	0.00509	CcSEcCtD
Danazol—Constipation—Omeprazole—Barrett's esophagus	0.00202	0.00505	CcSEcCtD
Danazol—Constipation—Esomeprazole—Barrett's esophagus	0.00202	0.00505	CcSEcCtD
Danazol—Urticaria—Omeprazole—Barrett's esophagus	0.00187	0.00469	CcSEcCtD
Danazol—Urticaria—Esomeprazole—Barrett's esophagus	0.00187	0.00469	CcSEcCtD
Danazol—Body temperature increased—Omeprazole—Barrett's esophagus	0.00186	0.00467	CcSEcCtD
Danazol—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00186	0.00467	CcSEcCtD
Danazol—CCL2—AP-1 transcription factor network—CXCL8—Barrett's esophagus	0.00186	0.0104	CbGpPWpGaD
Danazol—PGR—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00181	0.0102	CbGpPWpGaD
Danazol—AR—Nuclear Receptors—PPARG—Barrett's esophagus	0.00174	0.00981	CbGpPWpGaD
Danazol—CCL2—Unfolded Protein Response (UPR)—CXCL8—Barrett's esophagus	0.0017	0.00958	CbGpPWpGaD
Danazol—Asthenia—Esomeprazole—Barrett's esophagus	0.00169	0.00424	CcSEcCtD
Danazol—Asthenia—Omeprazole—Barrett's esophagus	0.00169	0.00424	CcSEcCtD
Danazol—Pruritus—Omeprazole—Barrett's esophagus	0.00167	0.00418	CcSEcCtD
Danazol—Pruritus—Esomeprazole—Barrett's esophagus	0.00167	0.00418	CcSEcCtD
Danazol—CCL2—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.00164	0.00923	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.0016	0.00897	CbGpPWpGaD
Danazol—Dizziness—Omeprazole—Barrett's esophagus	0.00156	0.00391	CcSEcCtD
Danazol—Dizziness—Esomeprazole—Barrett's esophagus	0.00156	0.00391	CcSEcCtD
Danazol—Vomiting—Esomeprazole—Barrett's esophagus	0.0015	0.00375	CcSEcCtD
Danazol—Vomiting—Omeprazole—Barrett's esophagus	0.0015	0.00375	CcSEcCtD
Danazol—Rash—Esomeprazole—Barrett's esophagus	0.00149	0.00372	CcSEcCtD
Danazol—Rash—Omeprazole—Barrett's esophagus	0.00149	0.00372	CcSEcCtD
Danazol—Dermatitis—Omeprazole—Barrett's esophagus	0.00149	0.00372	CcSEcCtD
Danazol—Dermatitis—Esomeprazole—Barrett's esophagus	0.00149	0.00372	CcSEcCtD
Danazol—Headache—Esomeprazole—Barrett's esophagus	0.00148	0.0037	CcSEcCtD
Danazol—Headache—Omeprazole—Barrett's esophagus	0.00148	0.0037	CcSEcCtD
Danazol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00146	0.00818	CbGpPWpGaD
Danazol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00146	0.00818	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00144	0.00809	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—CDX2—Barrett's esophagus	0.00141	0.00791	CbGpPWpGaD
Danazol—Nausea—Esomeprazole—Barrett's esophagus	0.0014	0.00351	CcSEcCtD
Danazol—Nausea—Omeprazole—Barrett's esophagus	0.0014	0.00351	CcSEcCtD
Danazol—AR—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00138	0.00775	CbGpPWpGaD
Danazol—CYP19A1—Biological oxidations—CYP26A1—Barrett's esophagus	0.00136	0.00766	CbGpPWpGaD
Danazol—CYP19A1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00134	0.00756	CbGpPWpGaD
Danazol—ESR1—Nuclear Receptors—PPARG—Barrett's esophagus	0.00134	0.00755	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00132	0.0074	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—PTGS2—Barrett's esophagus	0.00126	0.00709	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.00122	0.00688	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—TP53—Barrett's esophagus	0.00121	0.0068	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—TP53—Barrett's esophagus	0.0012	0.00672	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—TP53—Barrett's esophagus	0.00114	0.00641	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—Barrett's esophagus	0.00113	0.00635	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.0011	0.00621	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—SST—Barrett's esophagus	0.0011	0.00616	CbGpPWpGaD
Danazol—ESR1—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00106	0.00597	CbGpPWpGaD
Danazol—ESR1—FOXM1 transcription factor network—CDKN2A—Barrett's esophagus	0.00104	0.00587	CbGpPWpGaD
Danazol—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.00101	0.00567	CbGpPWpGaD
Danazol—AR—Coregulation of Androgen receptor activity—CDKN2A—Barrett's esophagus	0.00101	0.00565	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—SST—Barrett's esophagus	0.001	0.00563	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—Barrett's esophagus	0.000997	0.0056	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.00095	0.00534	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000934	0.00525	CbGpPWpGaD
Danazol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000924	0.00519	CbGpPWpGaD
Danazol—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000912	0.00513	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000908	0.0051	CbGpPWpGaD
Danazol—CCL2—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.000836	0.0047	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—GAST—Barrett's esophagus	0.000827	0.00465	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—GAST—Barrett's esophagus	0.000821	0.00461	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—Barrett's esophagus	0.000809	0.00455	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TP53—Barrett's esophagus	0.000751	0.00422	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—GAST—Barrett's esophagus	0.000751	0.00422	CbGpPWpGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000749	0.00421	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—Barrett's esophagus	0.000734	0.00412	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000724	0.00407	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—CXCL8—Barrett's esophagus	0.000721	0.00405	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—RELA—Barrett's esophagus	0.000715	0.00402	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—CDKN2A—Barrett's esophagus	0.000694	0.0039	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000691	0.00388	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.000672	0.00378	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—RELA—Barrett's esophagus	0.000632	0.00355	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—CXCL8—Barrett's esophagus	0.000629	0.00354	CbGpPWpGaD
Danazol—ESR1—LKB1 signaling events—TP53—Barrett's esophagus	0.00057	0.0032	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—SST—Barrett's esophagus	0.000567	0.00318	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—SST—Barrett's esophagus	0.000562	0.00316	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000561	0.00315	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000558	0.00313	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—SST—Barrett's esophagus	0.000514	0.00289	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000513	0.00288	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000497	0.00279	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—GAST—Barrett's esophagus	0.000485	0.00272	CbGpPWpGaD
Danazol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000479	0.00269	CbGpPWpGaD
Danazol—PGR—Gene Expression—NR1I2—Barrett's esophagus	0.000457	0.00257	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—GAST—Barrett's esophagus	0.000443	0.00249	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.00043	0.00242	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000427	0.0024	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000398	0.00224	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000392	0.00221	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—CXCL8—Barrett's esophagus	0.000391	0.0022	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—TP53—Barrett's esophagus	0.000386	0.00217	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000383	0.00215	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000377	0.00212	CbGpPWpGaD
Danazol—AR—Gene Expression—NR1I2—Barrett's esophagus	0.000349	0.00196	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SST—Barrett's esophagus	0.000332	0.00187	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000313	0.00176	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGES—Barrett's esophagus	0.000308	0.00173	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SST—Barrett's esophagus	0.000304	0.00171	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—CXCL8—Barrett's esophagus	0.0003	0.00169	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000291	0.00163	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GAST—Barrett's esophagus	0.00028	0.00157	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	0.000271	0.00152	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NR1I2—Barrett's esophagus	0.000268	0.00151	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000238	0.00134	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP26A1—Barrett's esophagus	0.000233	0.00131	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	0.000233	0.00131	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000225	0.00126	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—CXCL8—Barrett's esophagus	0.000221	0.00124	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CXCL8—Barrett's esophagus	0.000219	0.00123	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	0.000209	0.00117	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CXCL8—Barrett's esophagus	0.0002	0.00113	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SST—Barrett's esophagus	0.000192	0.00108	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000183	0.00103	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—APC—Barrett's esophagus	0.000176	0.000988	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000173	0.000972	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000172	0.000968	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SLC9A1—Barrett's esophagus	0.000168	0.000945	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GAST—Barrett's esophagus	0.000164	0.000922	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—APC—Barrett's esophagus	0.000161	0.000904	CbGpPWpGaD
Danazol—PGR—Gene Expression—PPARG—Barrett's esophagus	0.000151	0.000846	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—RELA—Barrett's esophagus	0.000137	0.000772	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000136	0.000762	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CXCL8—Barrett's esophagus	0.000129	0.000728	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—RELA—Barrett's esophagus	0.000126	0.000706	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CXCL8—Barrett's esophagus	0.000118	0.000665	CbGpPWpGaD
Danazol—AR—Gene Expression—PPARG—Barrett's esophagus	0.000115	0.000645	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SST—Barrett's esophagus	0.000112	0.000632	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APC—Barrett's esophagus	0.000101	0.00057	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGES—Barrett's esophagus	8.98e-05	0.000505	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPARG—Barrett's esophagus	8.83e-05	0.000497	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—Barrett's esophagus	7.94e-05	0.000447	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RELA—Barrett's esophagus	7.92e-05	0.000445	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPARG—Barrett's esophagus	7.67e-05	0.000431	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CXCL8—Barrett's esophagus	7.47e-05	0.00042	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—Barrett's esophagus	7.27e-05	0.000408	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	6.8e-05	0.000382	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—Barrett's esophagus	6.04e-05	0.000339	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APC—Barrett's esophagus	5.95e-05	0.000334	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	4.91e-05	0.000276	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RELA—Barrett's esophagus	4.65e-05	0.000261	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—Barrett's esophagus	4.58e-05	0.000258	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCL8—Barrett's esophagus	4.38e-05	0.000246	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—Barrett's esophagus	2.69e-05	0.000151	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARG—Barrett's esophagus	2.24e-05	0.000126	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	1.76e-05	9.9e-05	CbGpPWpGaD
